Cns Pharmaceuticals Inc (CNSP) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $3.07
• Market Cap: $1.72M
• EPS: $776.03
• 52-Week High: $55.20
• 52-Week Low: $2.95

Market Sentiment

Cns Pharmaceuticals Inc currently has a Bullish sentiment score of 0.23.

About Cns Pharmaceuticals Inc

CNS Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company headquartered in Houston, Texas, dedicated to innovating therapies for brain and central nervous system tumors. The company is advancing its lead developmental candidate, which targets significant unmet medical needs in oncology, particularly in neuro-oncology. Leveraging a strong scientific foundation and strategic collaborations, CNS Pharmaceuticals is committed to improving patient outcomes and addressing the critical ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Cns Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CNSP pay dividends?

Cns Pharmaceuticals Inc (CNSP) does not currently pay a regular dividend.

What is CNSP's market cap?

Cns Pharmaceuticals Inc (CNSP) has a market capitalization of $1.72M with a current stock price of $3.07.